Len Rosen

Mr. Rosen was most recently the CEO of Barclays Israel, and before that held the same position at Lehman Brothers. Over the course of his 25-year career as a trusted advisor to clients in Israel, he has advised clients on many of the largest and most important M&A transactions, including Orbotech's sale to KLA, Orbotech's acquisitions of Photon Dynamics and Frontline, Given Imaging's sale to Covidien, Verint's acquisition of Witness Systems, SuperDerivatives' sale to ICE Noble Energy's sale of a stake in the Tamar natural gas field and a number of acquisitions for Teva Pharmaceuticals. In addition, Mr. Rosen has been involved in over 100 IPOs and equity transactions, including the IPOs of Ormat Geothermal, Verint, Mobileye, CyberArk, ADO Properties, ReWalk, Foamix, Kornit and Caesarstone. He has also been involved in over 60 fixed income transactions for Israel and Israeli companies, including the sovereign, Israel Electric and the emerging Israeli companies in the natural gas sector.